Combined fracture and mortality risk evaluation for stratifying treatment in hip fracture patients: A feasibility study

• Published in: Joint diseases and related surgery Vol. 31; no. 2; pp. 163 - 168
• Main Authors: Sezgin, Erdem Aras, Markevičiūtė, Vėtra, Širka, Aurimas, Tarasevičius, Šarūnas, Raina, Deepak Bushan, Isaksson, Hanna, Tägil, Magnus, Lidgren, Lars
• Format: Journal Article
• Language: English
• Published: Turkey Bayçınar Medical Publishing 01.01.2020
• Subjects: Original
• ISSN: 2687-4784; 2687-4792
• DOI: 10.5606/ehc.2020.73458

This study aims to test the feasibility of the Fracture and Mortality Risk Evaluation (FAME) Index. Two academic centers in Lithuania and Turkey participated in this retrospective study conducted between November 2018 and July 2019. A total of 100 consecutive patients (22 males, 78 females; mean age 78.9 years; range, 45 to 100 years) with low energy proximal femur fractures admitted for surgery were included in the study. Fracture Risk Assessment tool (FRAX) and the Sernbo scores were calculated and patients were classified into one of the nine subcategories of the FAME Index. Demographics and FAME Index classifications were similar between centers. Patients with high risk of fracture and low risk of mortality accounted for 18% of all patients, which is the FAME Index subcategory to theoretically benefit from cancellous bone augmentation during internal fixation of a fragility hip fracture the most. The FAME Index was successfully applied in clinical emergency setting utilizing a simple form, and demonstrated promising potential in stratification of hip fractures most suitable for screw and device augmentation. Larger studies with at least one-year of follow-up are warranted to verify the validity of FAME Index.